Oligonucleotides: A Cornerstone for Therapeutics & More
ISPE
OCTOBER 27, 2022
Since 2016, drug approvals per clinical campaign have outpaced the average across all modalities, resulting in 11 FDA-approved therapies in that span. Combining the incremental process improvements previously mentioned results in an optimized facility, with the adjusted block flow shown in Figure 5. Cell & Gene Therapy.
Let's personalize your content